GAYLA JOHNSON: Open Payments
NPI 1033500673 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,213 in 84 payments from 16 companies in 2025. Trend: 2023 $920 · 2024 $939 · 2025 $1,213
Food & beverage: $1,213
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $170 |
| Amgen Inc. | 22 | $168 |
| AstraZeneca Pharmaceuticals LP | 6 | $146 |
| Novartis Pharmaceuticals Corporation | 7 | $139 |
| Alnylam Pharmaceuticals Inc. | 10 | $136 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $90 |
| Regeneron Healthcare Solutions, Inc. | 3 | $79 |
| Kestra Medical Technology Services, Inc. | 3 | $75 |
| Medtronic, Inc. | 3 | $50 |
| Merck Sharp & Dohme LLC | 3 | $44 |
Products named: JARDIANCE, REPATHA, AMVUTTRA, FARXIGA, LEQVIO, LifeVest, EVKEEZA, Assure WCD.
Industry payments across AR — which companies pay providers there.
